Bio-Techne
TECH
#2271
Rank
NZ$14.36 B
Marketcap
NZ$91.81
Share price
-4.80%
Change (1 day)
-19.21%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): NZ$0.91

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is NZ$0.87. In 2024 the company made an earnings per share (EPS) of NZ$1.68 a decrease over its 2023 EPS that were of NZ$2.38.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.91-45.6%
2024NZ$1.68-29.58%
2023NZ$2.38-14.97%
2022NZ$2.8024.16%
2021NZ$2.2617.98%
2020NZ$1.91-10.94%
2019NZ$2.15101.57%
2018NZ$1.06-16.99%
2017NZ$1.2845.02%
2016NZ$0.88-20.97%
2015NZ$1.12-14.97%
2014NZ$1.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$29.79 3,317.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.34 971.15%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$13.78 1,480.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$8.50 875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.30 278.28%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.35-140.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ-$40.76-4,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA